Compare ADMA Biologics Inc (ADMA) vs Manhattan Associates Inc (MANH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Manhattan Associates Inc — how do they compare? ADMA Biologics Inc trades at $9.87 (market cap $2.22B), while Manhattan Associates Inc trades at $192.22 (market cap $11.38B). The key difference: Manhattan Associates Inc is far larger — about 5.1× ADMA Biologics Inc's market cap, and Manhattan Associates Inc is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | MANH | |
|---|---|---|
Market Cap | $2.22B | $11.38B |
Sector | Health | Technology |
52-Week High | $20.38 | $220.19 |
52-Week Low | $7.60 | $120.88 |
Enterprise Value | $2.29B | $11.25B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Manhattan Associates Inc
Manhattan Associates, Inc. is a global leader in supply chain and omnichannel commerce software. The company provides a comprehensive suite of cloud-based and on-premise solutions for warehouse management (WMS), transportation management (TMS), and order management (OMS). MANH's technology helps retailers, wholesalers, and manufacturers manage inventory, optimize logistics, and unify the shopping experience across physical and digital channels.
Read more on MANH →
